JP2019534285A5 - - Google Patents

Download PDF

Info

Publication number
JP2019534285A5
JP2019534285A5 JP2019522653A JP2019522653A JP2019534285A5 JP 2019534285 A5 JP2019534285 A5 JP 2019534285A5 JP 2019522653 A JP2019522653 A JP 2019522653A JP 2019522653 A JP2019522653 A JP 2019522653A JP 2019534285 A5 JP2019534285 A5 JP 2019534285A5
Authority
JP
Japan
Prior art keywords
patent document
application publication
document
pat
prior
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019522653A
Other languages
English (en)
Other versions
JP2019534285A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/058269 external-priority patent/WO2018081256A1/en
Publication of JP2019534285A publication Critical patent/JP2019534285A/ja
Publication of JP2019534285A5 publication Critical patent/JP2019534285A5/ja
Pending legal-status Critical Current

Links

Description

関連出願の相互参照
本出願は、2016年10月26日付け出願の米国仮出願第62/412,945号の利益を主張し、その全体が参照により本明細書に組み込まれる。
この出願の発明に関連する先行技術文献情報としては、以下のものがある(国際出願日以降国際段階で引用された文献及び他国に国内移行した際に引用された文献を含む)。
(先行技術文献)
(特許文献)
(特許文献1) 米国特許出願公開第2016/015829号明細書
(特許文献2) 米国特許出願公開第2012/0269721号明細書
(特許文献3) 米国特許第7,541,440号明細書
(特許文献4) 米国特許出願公開第2010/0183504号明細書
(特許文献5) 米国特許第8,180,436号明細書
JP2019522653A 2016-10-26 2017-10-25 放射エネルギーによる崩壊の標的とされる癌結合性放射線不透過性ペプチド Pending JP2019534285A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662412945P 2016-10-26 2016-10-26
US62/412,945 2016-10-26
PCT/US2017/058269 WO2018081256A1 (en) 2016-10-26 2017-10-25 Cancer binding radio-opaque peptides that are targeted for disintegration by radiant energy

Publications (2)

Publication Number Publication Date
JP2019534285A JP2019534285A (ja) 2019-11-28
JP2019534285A5 true JP2019534285A5 (ja) 2020-10-08

Family

ID=62023998

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019522653A Pending JP2019534285A (ja) 2016-10-26 2017-10-25 放射エネルギーによる崩壊の標的とされる癌結合性放射線不透過性ペプチド

Country Status (4)

Country Link
US (1) US20190274645A1 (ja)
JP (1) JP2019534285A (ja)
CN (1) CN109963875A (ja)
WO (1) WO2018081256A1 (ja)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7541440B2 (en) * 2002-09-30 2009-06-02 Immunomedics, Inc. Chimeric, human and humanized anti-granulocyte antibodies and methods of use
US20080058785A1 (en) * 2006-04-12 2008-03-06 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Autofluorescent imaging and target ablation
US20100183504A1 (en) * 2007-06-14 2010-07-22 Fanqing Frank Chen Multimodal imaging probes for in vivo targeted and non-targeted imaging and therapeutics
EP2862871A1 (en) * 2008-04-14 2015-04-22 The General Hospital Corporation Plectin-1 targeted agents for detection and treatment of pancreatic ductal adenocarcinoma
WO2011046842A1 (en) * 2009-10-12 2011-04-21 The Regents Of The University Of California Targeted nanoclusters and methods of their use
US8524239B2 (en) * 2010-07-09 2013-09-03 The United States of America as represented by the Secrectary, Department of Health and Human Services Photosensitizing antibody-fluorophore conjugates

Similar Documents

Publication Publication Date Title
JP2019502892A5 (ja)
JP2014513484A5 (ja)
JP2014519662A5 (ja)
JP2016511967A5 (ja)
JP2014519854A5 (ja)
JP2014525291A5 (ja)
JP2015531923A5 (ja)
JP2016153424A5 (ja)
JP2013540292A5 (ja)
JP2016506890A5 (ja)
JP2014138100A5 (ja)
JP2016506003A5 (ja)
JP2016523701A5 (ja)
JP2021505241A5 (ja)
JP2013519136A5 (ja)
JP2017505048A5 (ja)
JP2012074699A5 (ja)
JP2018525453A5 (ja)
JP2016527801A5 (ja)
JP2016516303A5 (ja)
JP2019527311A5 (ja)
JP2020528637A5 (ja)
JP2020512939A5 (ja)
JP2015508925A5 (ja)
JP2020500643A5 (ja)